TFX - Teleflex Incorporated

NYSE - NYSE Delayed Price. Currency in USD

Teleflex Incorporated

550 East Swedesford Road
Suite 400
Wayne, PA 19087
United States
610-225-6800
http://www.teleflex.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees15,200

Key Executives

NameTitlePayExercisedYear Born
Mr. Liam J. KellyPres, CEO & Director2.29MN/A1967
Mr. Thomas E. PowellExec. VP & CFO1.16M12.36M1962
Mr. James J. LeydenVP, Gen. Counsel & Sec.576.33k290.37k1967
Mr. Cameron P. HicksVP of Global HR & Employee Communications539.29k353.24k1965
Mr. John R. DerenVP & Chief Accounting OfficerN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

Corporate Governance

Teleflex Incorporated’s ISS Governance QualityScore as of February 3, 2020 is 8. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.